Belgium· BE-AMP-SAM327433-00
Evicel 250 mg - 450 mg - 4000 IU - 6000 IU
A local hemostatics product containing human clottable proteins, registered in Belgium by Omrix Biopharmaceuticals. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Human clottable proteins is registered in 7 of 19 countries.
Countries holding a registration under ATC B02BC (local hemostatics), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Human clottable proteins · ATC B02BC
7 / 19 countries
- Belgiumprice
- Finlandprice
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Human Clottable Proteins
- Manufacturer
- Omrix Biopharmaceuticals
- Country
- Belgium (BE)
- ATC code
- B02BC
- ATC class
- Local hemostatics
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7703101
- be_apb3040458
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02BC
Local hemostatics, as other registers publish it.
- IrelandARTISS Solutions for Sealant, deep frozenBaxter Holding B.V.
- BelgiumEvicel 100 mg - 180 mg - 1600 IU - 2400 IUOmrix Biopharmaceuticals
- BelgiumEvicel 50 mg - 90 mg - 800 IU - 1200 IUOmrix Biopharmaceuticals
- NorwayJärnklorid aplApoteket Produktion & Laboratorier
- FinlandTisseel LyoBaxter AG
- IrelandTISSEEL Lyo Powder and Solvent for SealantBaxter Holding B.V.
- IrelandTISSEEL Ready to use Solutions for SealantBaxter Holding B.V.
- IcelandVeraSealInstituto Grifols S.A.*
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf60a67e-f8cd-4ade-867d-9b3433cbc708 GET /v1/drugs/bf60a67e-f8cd-4ade-867d-9b3433cbc708?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for sealant",
"source": "afmps",
"status": "REVOKED",
"name_en": "Evicel 250 mg - 450 mg - 4000 IU - 6000 IU",
"name_fr": "Evicel 250 mg - 450 mg - 4000 IU - 6000 IU",
"name_nl": "Evicel 250 mg - 450 mg - 4000 IU - 6000 IU",
"amp_code": "SAM327433-00",
"strengths": null,
"pack_count": 1,
"substances": [
"Human Clottable Proteins",
"Mannitol",
"Sodium Acetate",
"Sodium Chloride",
"Human Thrombin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Local Hemostatics",
"authorisation_numbers": [
"EU/1/08/473/003"
]
}See everything about human clottable proteins.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.